Medtronic (NYSE:MDT) is expected to publish its Q4 fiscal 2019 results on May 23. You can view our interactive dashboard analysis ~ How Is Medtronic Likely To Have Fared In Q4 Fiscal 2019? Medtronic reports its revenues under four segments ~ Cardiac & Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes. They grew from $7.37 billion in Q3 fiscal 2018 to $7.55 billion in Q3 fiscal 2019. Medtronic’s adjusted earnings per share will likely be $1.46 per share in Q4 fiscal 2019, reflecting 2.6% growth to the prior year quarter.

Source: Forbes May 22, 2019 19:16 UTC